A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced Hypotension

Clinical trial NCT06608901 · COMPLETED

Trial details

NCT number: NCT06608901
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sepsis-Induced Hypotension

Start date: 2025-05-05
Primary completion: 2026-02-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.